FABP3 Protein Promotes α-Synuclein Oligomerization Associated with 1-Methyl-1,2,3,6-tetrahydropiridine-induced Neurotoxicity

G51D α-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome

(2013) Suzanne Lesage et al.   ANNALS OF NEUROLOGY

In VivoCross-linking Reveals Principally Oligomeric Forms of α-Synuclein and β-Synuclein in Neurons and Non-neural Cells

(2013) Ulf Dettmer et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A novel  -synuclein missense mutation in Parkinson disease

(2013) C. Proukakis et al.   NEUROLOGY

Overexpression ofFABP3promotes apoptosis through inducing mitochondrial impairment in embryonic cancer cells

(2012) Gui Xian Song et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

In vivo demonstration that  -synuclein oligomers are toxic

(2011) B. Winner et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Heart-Type Fatty Acid Binding Protein Regulates Dopamine D2 Receptor Function in Mouse Brain

(2010) N. Shioda et al.   JOURNAL OF NEUROSCIENCE

5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson’s disease

(2010) Marcus C. Ferguson et al.   NEUROPHARMACOLOGY

Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain

(2008) Latha Devi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Serum heart-fatty acid binding protein levels in patients with Lewy body disease

(2007) Kenji Wada-Isoe et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES